Drug Delivery Systems Market Research Reports & Industry Analysis
Drug Delivery Systems Industry Research & Market Reports
-
Liposomal Drug Delivery Devices Global Market Report 2022 Including: 1) By Type: Liposomal Doxorubicin; Liposomal Paclitaxel; Liposomal Amphotericin B; Other Types 2) By Application: Fungal Diseases; Cancer Therapy; Pain Management; Viral Vaccines; Photodynamic Therapy 3) By End User: Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Other End Users Covering: Fudan-Zhangjiang; Pacira; Johnson and Johnson; Gilead Sciences; Novartis; Luye Pharma; CSPC; Ipsen (Onivyde); Teva Pharmaceutical
... assess the global liposomal drug delivery devices market. This report focuses on liposomal drug delivery devices market which is experiencing strong growth. The report gives a guide to the liposomal drug delivery devices market which ... Read More
-
Drug-device Combination Products Market, by Product Type (Drug Eluting Stents  (Coronary Stent, and Peripheral Vascular Stents), Infusion Pumps (Implantable and Ambulatory), Photosensitizers, Orthopedic Combination Products, Wound Care Combination Produ
... and Metered Dose Inhaler)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, ... Read More
-
North America Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Delivery, and Others)
... The bioresorbable polymers market in North America is expected to grow from US$ 1,189.92 million in 2021 to US$ 2,499.56 million by 2028; it is estimated to grow at a CAGR of 11.2% from 2021 ... Read More
-
Asia Pacific Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Delivery, and Others)
... The bioresorbable polymers market in Asia Pacific is expected to grow from US$ 782.77 million in 2021 to US$ 1,697.06 million by 2028; it is estimated to grow at a CAGR of 11.7% from 2021 ... Read More
-
Middle East and Africa Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Delivery, and Others)
... and Others) The bioresorbable polymers market in Middle East & Africa is expected to grow from US$ 179.64 million in 2021 to US$ 255.34 million by 2028; it is estimated to grow at a CAGR ... Read More
-
Europe Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Delivery, and Others)
... bioresorbable polymers market in Europe is expected to grow from US$ 996.36 million in 2021 to US$ 1,860.37 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2021 to 2028. ... Read More
-
South America Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Delivery, and Others)
... The bioresorbable polymers market in South America is expected to grow from US$ 111.37 million in 2021 to US$ 150.74 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2021 ... Read More
-
Leading Intrathecal Pumps Country Markets Databank
... 2029. Asia-Pacific is expected to be the highest contributor to this market, with $59.2 Million in 2020, and is anticipated to reach $177.4 Million by 2029, registering a CAGR of 13.02%. Asia-Pacific and North America ... Read More
-
North America Intrathecal Pumps Market Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
-
Asia-Pacific Connected Drug Delivery Devices Market Databank
... from 2021 to 2029. Integrated devices segment is expected to be the highest contributor to this market, with $252.1 Million in 2020, and is anticipated to reach $587.2 Million by 2029, registering a CAGR of ... Read More
-
Male Hypogonadism Market By Drug Delivery (Topical Gels, Injectables, Transdermal Patches, Others), By Therapy (Testosterone Replacement Therapy, Gonadotropin and Gonadotropin Releasing Hormone Therapy), By Type (Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
... and Industry Forecast, 2020-2030 The global male hypogonadism market was valued $ 3,072.86 million in 2020 and expected to reach $ 5,085.03 million by 2030, with a CAGR of 5.1% from 2021 to 2030. Hypogonadism ... Read More
-
Leading Intrathecal Pumps Type Markets Databank
... 2029. Baclofen segment is expected to be the highest contributor to this market, with $65.3 Million in 2020, and is anticipated to reach $181.1 Million by 2029, registering a CAGR of 12.05%. Baclofen and Bupivacaine ... Read More
-
Global Intrathecal Pumps Market Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
-
Leading Connected Drug Delivery Devices Technology Markets Databank
... 9.92% from 2021 to 2029. Service segment is expected to be the highest contributor to this market, with $163.2 Million in 2020, and is anticipated to reach $377.5 Million by 2029, registering a CAGR of ... Read More
-
Asia-Pacific Intrathecal Pumps Market Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
-
Europe Connected Drug Delivery Devices Market Databank
... from 2021 to 2029. Integrated devices segment is expected to be the highest contributor to this market, with $252.1 Million in 2020, and is anticipated to reach $587.2 Million by 2029, registering a CAGR of ... Read More
-
Connected Drug Delivery Devices Market : Segmented By Technology (Bluetooth, NFC and Others): By End-User Product (Connected Sensors, Integrated Connected Devices and Others) Global Analysis By Market Size, Share & Trends For 2020-2021 And Forecasts To 2031
... To 2031 Product overview Connected drug delivery devices are the kind of machines which are used to provide various medicinal agents in a patient’s body to offer medical treatment and monitor a patient’s behavior. These ... Read More
-
Europe Intrathecal Pumps Market Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
-
Leading Connected Drug Delivery Devices Device Type Markets Databank
... of 9.92% from 2021 to 2029. Integrated devices segment is expected to be the highest contributor to this market, with $252.1 Million in 2020, and is anticipated to reach $587.2 Million by 2029, registering a ... Read More
-
Latin America, Middle East & Africa Intrathecal Pumps Market Databank
... 11.87% from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of ... Read More
-
2022 Global Electronic Drug Delivery Systems Industry (2028 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include ... Read More
-
Global Connected Drug Delivery Devices Market Databank
... from 2021 to 2029. Integrated devices segment is expected to be the highest contributor to this market, with $252.1 Million in 2020, and is anticipated to reach $587.2 Million by 2029, registering a CAGR of ... Read More
-
Leading Connected Drug Delivery Devices Country Markets Databank
... 9.92% from 2021 to 2029. Asia-Pacific is expected to be the highest contributor to this market, with $128.9 Million in 2020, and is anticipated to reach $345.7 Million by 2029, registering a CAGR of 11.63%. ... Read More
-
Leading Intrathecal Pumps Application Markets Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
-
Novel Cardiovascular Drug Delivery Devices Market, 2022-2035
... WHO, around one third of the annual global deaths (an estimated 18 million) can be attributed to cardiac disorders. Specifically, coronary artery disease (CAD) is the most common form of cardiovascular disorder; around 11 million ... Read More
Research Assistance
